32 /100
MEDIUM RISK
Score updated May 30, 2026

GOSS — Gossamer Bio, Inc. Dilution Risk Tracker

Track GOSS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GOSS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
40
📊 Float Risk
12
⚠️ Warrant Exposure
50
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
32%
🔄 Reverse Split 55%
• 50-day avg $0.34 below $1 exchange minimum
📜 Warrant Exercise 15%
• Warrant overhang: 13.8% of shares outstanding
🔔 Track GOSS — Get forecast alerts →

💹 Market Data

Market Cap$54.19M
Shares Outstanding234.70M
Float227.18M
Cash$99.22M
Debt$202.93M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 50.1% shares (2026Q1 vs prior)
10 institutional holders · 96.76M shares
#1 NEA Management Company, LLC 18.09M shares
#2 Octagon Capital Advisors LP 17.05M shares
#3 Blackrock Inc. 13.85M shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest40.84M
Days to Cover11.5
% of Float18.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2022
Form 4 INSIDER TRANSACTION Jan 02, 2026
Form 4 INSIDER TRANSACTION Jan 02, 2026
Form 4 INSIDER TRANSACTION Jan 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track GOSS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GOSS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for GOSS
📊 GOSS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GOSS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.